title: Infliximab and adalimumab use during breastfeeding.
authors.forename: Juliane
authors.initials: J
authors.lastname: Fritzsche
authors.forename: Anna
authors.initials: A
authors.lastname: Pilch
authors.forename: Dina
authors.initials: D
authors.lastname: Mury
authors.forename: Christof
authors.initials: C
authors.lastname: Schaefer
authors.forename: Corinna
authors.initials: C
authors.lastname: Weber-Schoendorfer
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects* / Q000493:pharmacokinetics; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage* / Q000009:adverse effects* / Q000493:pharmacokinetics; D001942:Breast Feeding; D005260:Female; D006801:Humans; D007223:Infant; D000069285:Infliximab; D008895:Milk, Human / Q000737:chemistry*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069285:Infliximab; D000068879:Adalimumab